It is consistent with recent research, which has proven that IGFBP7, together with the tissue inhibitor of metalloproteinases-2 (TIMP-2), is a novel marker of tubular damage, and it can be used for the early detection of acute-kidney-injury (AKI)-endangered patients. This evidence concerns the gene TIMP2 and acute kidney injury.